General News Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…John BuckleyNovember 22, 2021
General News Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…John BuckleySeptember 27, 2021
Psychiatry News Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…John BuckleyFebruary 17, 2021
Psychiatry News Saladax Hires 8 to Address Demand for Schizophrenia Medication Test Saladax Biomedical, Inc., Ben Franklin TechVentures, Bethlehem, has expanded its staff with eight new employees in…John BuckleyOctober 13, 2020
MyCare InsitePsychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…John BuckleyJuly 8, 2020
MyCare InsitePsychiatry News HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…John BuckleyJune 27, 2020
MyCare InsitePsychiatry News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…John BuckleyMay 4, 2020
MyCare InsitePsychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…John BuckleyMay 1, 2020
MyCare InsitePsychiatry News Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…John BuckleyOctober 24, 2019
General News Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…John BuckleySeptember 27, 2021
General News Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…John BuckleyOctober 28, 2016
MyCare InsitePsychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…John BuckleyJuly 8, 2020
MyCare InsitePsychiatry News HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…John BuckleyJune 27, 2020
MyCare InsitePsychiatry News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…John BuckleyMay 4, 2020
MyCare InsitePsychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…John BuckleyMay 1, 2020
MyCare InsitePsychiatry News Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…John BuckleyOctober 24, 2019
MyCare InsitePsychiatry News Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…John BuckleySeptember 5, 2019
Psychiatry News Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…John BuckleySeptember 19, 2018
Psychiatry News Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…John BuckleyJune 26, 2018
Psychiatry News Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…John BuckleyMarch 21, 2018